Home Team/Management>
Latest News
See all news



Gilles Alberici

Gilles Alberici, PharmD, PhD is a Pharmacist and Doctor in Immunology. From 1994 to 1999, he founded and directed IMTIX -within Pasteur-Merieux- then IMTIX-SangStat. More recently, from 1999 to 2007, he developed OPi, Pharmaceuticals for rare diseases. Since 2006, Gilles manages OCTALFA, a family-owned independent investment company specializing in Life Sciences, and the Dominique Alberici-Octalfa Foundation.

Jeremy Bastid

Jeremy Bastid, PharmD, PhD, is Doctor of Pharmacy and Doctor in Cellular, Molecular Biology and Oncology, and specialized in immuno-oncology. Jeremy held several positions at the Hospices Civils de Lyon, at the Faculty of Pharmacy and at the University Claude Bernard Lyon 1. He performed fundamental research in oncology at the INSERM U590 in the Centre Léon-Bérard (Lyon) and received the Louis-Fontaine Prize (Merck) for his research. He joined initiative OCTALFA as R&D Director and is Chief Operating Officer of OREGA Biotech. See Jeremy’s publications.

Nathalie Bonnefoy

Nathalie Bonnefoy, PhD, Doctor in Immunology - Research Director at the INSERM unit U896 located at the Institut de Recherche en Cancérologie de Montpellier (IRCM). Nathalie was group leader at INSERM U851 in Lyon (2003-2012) and is now the head of the « Immunity and cancer » team developing translational research projects in the field of cancer and immunity. Nathalie Bonnefoy is author of more than 50 scientific peer reviewed publications and book chapters. See Nathalie’s publications.

Jean-François Eliaou

Jean-François Eliaou, MD, PhD, is Professor of Medicine in Immunology. Head of the Department of Immunology at the University Hospital of Montpellier and Medical School of the Montpellier University, and member of INSERM U896, Jean-François Eliaou possesses recognized expertise in the field of Immunogenetics, Transplantation Immunology and autoimmune and chronic inflammatory diseases. He is President of the Société Francophone d'Histocompatibilité et d'Immunologie (SFHI) and author of more than 60 scientific peer reviewed publications. See Jean-François’s publications.

Armand Bensussan

Armand Bensussan, PhD - Research Director at the INSERM, was President of the French Society of Immunology from 2007 to 2009. He was the head of two INSERM laboratories at the Henri Mondor hospital in Créteil and is now Director of the Skin Research Center and the INSERM unit 976 at Saint-Louis Hospital in Paris. He is author of 250 international publications and several books. Armand is a recognized expert in the field of monoclonal antibodies with more than 50 mAbs out-licenced to the industry. Armand is a member of the Human Leucocyte Differentiation Antigens committee (which established the CD nomenclature) and of the EuromAbnet committee. He obtained two French Academy of Sciences awards, the Clinical Investigation award from the Foundation for Medical Research, the Immunology Bernard Halpern award. See Armand’s publications.

See all events